Tolerance to bronchodilating effects of salmeterol in COPD (Q44596239)

4 December 2017

title

Tolerance to bronchodilating effects of salmeterol in COPD (English)

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(03)00131-8

14 March 2024

author name string

J. F. Donohue

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509555

14 March 2024

S. Menjoge

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509555

14 March 2024

S. Kesten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509555

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14509555

14 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

http://www.resmedjournal.com/article/S0954611103001318/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509555

https://api.elsevier.com/content/article/PII:S0954611103001318?httpAccept=text/xml

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(03)00131-8

https://api.elsevier.com/content/article/PII:S0954611103001318?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(03)00131-8

14 March 2024

1 reference

4 December 2017

volume

97

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1014-1020

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Quality of life changes in COPD patients treated with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900131-8

7 January 2021

Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects

series ordinal

9

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(03)00131-8

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference